EMR-62218

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEMR-62218
Drug Alias NameEMR-62218
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsSchizophreniaSleep Wake Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono
Active IndicationsN/A
Inactive IndicationsSchizophreniaSleep Wake Disorders

Other Information

ATC CodeN/A
Related LinksN/A